- €490.81m
- €1.20bn
- €1.09bn
- 64
- 94
- 24
- 67
Annual income statement for Quadient SA, fiscal year end - January 31st, EUR millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | R2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,029 | 1,024 | 1,071 | 1,062 | 1,093 |
| Cost of Revenue | |||||
| Gross Profit | 744 | 744 | 785 | 788 | 818 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 934 | 909 | 1,004 | 930 | 970 |
| Operating Profit | 95.9 | 116 | 67.2 | 132 | 123 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 64.3 | 108 | 31.7 | 101 | 84.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 40.5 | 88.2 | 15 | 84.3 | 66.9 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 40.4 | 87.8 | 13.3 | 68.7 | 66.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 31.5 | 78.9 | 9.9 | 68.7 | 66.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.59 | 2.37 | 1.43 | 2.98 | 2.47 |
| Dividends per Share |